to the development of a unique expertise for the
design and manufacturing
of high-quality medical devices,
intended for cells therapies and for the preparation of
autologous platelet-rich plasma (PRP)
from the patient’s own blood, to be used in bedside procedures.
Musculoskeletal
CellularMatrix® Synergistically combines the complementary clinical effects of A-PRP and HA to provide added benefit for OA patients.
RegenKit® Extracell Glue Bone Marrow Concentrate (BMC) autologous cell concentrate from bone marrow aspirate.
Gynecology
About RegenLab SA
Swiss manufacturer of Class II & III Medical Devices for autologous blood cell preparations, hyaluronic acid, and bone marrow cell extracts.
In the last five years, over 2 million patients have been treated using Regen Lab products and another 10 thousand have benefited from bone marrow kits. The company invested in a new Good Manufacturing Practice (GMP) facility located at the Mont-sur-Lausanne (Switzerland) beginning production in 2016. It is planned that this new peak performance industrial platform will allow the treatment of over 1 million patients per year.
Patents
Intellectual Property Rights (IPRs) as Core Assets
As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community. Innovation represents one of the strongest pillars of the company with more than 30 in-house scientists and a unique network of talented and renowned medical doctors contributing to Regen Lab’s Research & Development.
Over nearly 15 years, this innovation has been secured by building substantial patent & trademarks portfolios. Intellectual Property Rights (IPRs) therefore represent core assets of the company protecting its unique products and forging Regen Lab’s renowned brand names.
The patent portfolio can be divided into two core technologies:
1-PRP/BMC gel devices, methods and uses thereof, alone or in combination with cell extracts and associated key technologies like Autologous Thrombin Serum (ATS) and PRP Cell Culture.
Associated trademarks are REGENLAB®, REGENKIT®, REGENACR®, PRP®, A-PRP®, REGENCELL®, REGENPLASMA®, REGEN PRP®, REGEN®, REGEN EXTRACELL®, THT®, cellularmask®, CUTECELL®, REGENVET®, A-CPKIT® which are registered trademarks of Regen Lab SA in Europe, United States and other countries.
2-Hyaluronic acid alone, cross-linked or not, or in combination with PRP/BMC leading to the unique “all in one” Cellular Matrix products combining in a synergetic manner the advantageous properties of PRP and HA, but also preparation in two separate devices.
Associated trademarks are REGENLAB®, REGENKIT®, CELLULAR MATRIX® fig., SKINVISC®, ARTHROVISC®, REGENMATRIX®, REGEN®, PRP® and A-PRP® which are registered trademarks of Regen Lab SA in Europe, United States and other countries.
Our Technologies
RegenKit® A-PRP
CellularMatrix™ A-PRP & HA
RegenExtracell® BMC
Quality Products
Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance. Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.
